Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization. 

Biotechnology

Medical Devices

Therapeutics

Corium

Mark Sirgo

Matthew Hand

Shay Etler

Jill Cafaro

Brittany Rivard

Magdalena C.

Denise Kim-O'Neill

Blythe Buchanan (she/her)

Tanya Bloker

Josephine Pedalino

Kevin Ostrander

John Neeley

Jeffrey Gaffey

Gary Cleary

Yi Xu

Charles Oh

The Medical Science Liaison Team at Corium is responsible for bridging the gap between clinical practice and product development by engaging with healthcare professionals, providing them with scientific and clinical information, and gathering insights to inform future research and product enhancements. This team plays a crucial role in facilitating communication between Corium and the medical community to ensure the effective and informed use of CNS therapies.

Medical Science Liaison Team

Marketing and Market Access

Leadership Team

Medical and Regulatory Affairs

Medical Science Liaison Team

About

Team members

Other teams at Corium

Marketing and Market Access

Leadership Team

Medical and Regulatory Affairs